Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study
Author:
Affiliation:
1. Clinical Oncology Department, Faculty of Medicine; Ain Shams University; Cairo Egypt
2. Department of Oncology; University of Calgary and Tom Baker Cancer Center; Calgary Alberta Canada
Publisher
Wiley
Subject
Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/crj.12950/fullpdf
Reference18 articles.
1. globocan.iarc.fr
2. Targeted therapy for localized non-small-cell lung cancer: a review;Paleiron;Onco Targets Ther,2016
3. Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis;Abdel-Rahman;Clin Respir J,2018
4. Keynote address on biostatistics and data retrieval;Zelen;Cancer Chemother Rep 3,1973
5. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Fruh;Ann Oncol,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer;Oncology;2024-08-05
2. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-07
3. Prognostic significance of body mass index in small‐cell lung cancer: Exploring the relationship with skeletal muscle status;Journal of Cachexia, Sarcopenia and Muscle;2023-11-20
4. Prognostic value of miR-219-5p in relation to mortality in patients with small cell lung cancer: a retrospective, observational cohort study in China;BMJ Open;2023-03
5. Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer;Frontiers in Oncology;2023-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3